Guardian Capital LP Abb Vie Inc. Transaction History

Guardian Capital LP

$2.47 Billion
Q3 2024

A detailed history of Guardian Capital LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Guardian Capital LP holds 73,873 shares of ABBV stock, worth $13.3 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

73,873

Previous 74,285 0.55%

Holding current value

$13.3 Million

Previous $12.7 Million 14.5%

% of portfolio

0.59%

Previous 0.53%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $67,502 - $82,123	-412 Reduced 0.55%	73,873 $14.6 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $27,707 - $32,356	-179 Reduced 0.24%	74,285 $12.7 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $2,077 - $2,367	13 Added 0.02%	74,464 $13.6 Million
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $106,777 - $120,256	-776 Reduced 1.03%	74,451 $11.5 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $1.54 Million - $1.79 Million	-11,565 Reduced 13.32%	75,227 $11.2 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $109,320 - $136,042	-825 Reduced 0.94%	86,792 $11.7 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $7,375 - $8,493	51 Added 0.06%	87,617 $14 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $31,258 - $37,486	-226 Reduced 0.26%	87,566 $14.2 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $5.42 Million - $6.22 Million	40,404 Added 85.26%	87,792 $11.8 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $6.52 Million - $8.29 Million	47,388 New	47,388 $7.26 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $5.65 Million - $6.65 Million	-73,238 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $4.29 Million - $5.29 Million	-55,084 Reduced 42.93%	73,238 $6.75 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $4.92 Million - $5.47 Million	-55,372 Reduced 30.14%	128,322 $12.1 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $187,370 - $221,702	-2,087 Reduced 1.12%	183,694 $17 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $320,194 - $428,770	3,480 Added 1.91%	185,781 $17.6 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $80,245 - $87,996	-896 Reduced 0.49%	182,301 $17.6 Million
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $48,825 - $62,364	699 Added 0.38%	183,197 $16.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	182,498	182,498 $13.2 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital LP with notifications on news.

Account

Guardian Capital LP Abb Vie Inc. Transaction History